Agilon Health (AGL) Long-Term Investments (2021 - 2023)

Agilon Health has reported Long-Term Investments for 3 years, with the latest figure at $5.1 million in Q1 2023.

• For the quarter ending Q1 2023, Long-Term Investments fell 28.86% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2023 stood at $5.1 million (down 28.86% YoY), and the FY2022 full-year result was $4.7 million, down 27.01% from the prior year.
• Long-Term Investments for Q1 2023 stood at $5.1 million, up from $4.7 million in the prior quarter.
• The five-year high for Long-Term Investments was $7.2 million in Q1 2022, with the low at $3.6 million in Q2 2022.
• Historically, Long-Term Investments has averaged $5.6 million across 3 years, with a median of $5.8 million in 2021.
• Annual changes were most pronounced in 2022 — Long-Term Investments fell 27.01% — and 2023, when it retreated 28.86%.
• Agilon Health's Long-Term Investments stood at $6.4 million in 2021, then retreated by 27.01% to $4.7 million in 2022, then gained by 10.5% to $5.1 million in 2023.
• The last three Long-Term Investments figures came in at $5.1 million (Q1 2023), $4.7 million (Q4 2022), and $6.4 million (Q3 2022), per Business Quant data.